INTRODUCTION
Mature mammalian cells can be reprogrammed to alternative fates by introduction of lineage-specific transcription regulators. For instance, Myod1 expression has been shown to induce a myocyte phenotype in fibroblast cultures (Davis et al., 1987) . Similarly, transduction of a set of pluripotency regulators is sufficient to convert skin fibroblasts to induced pluripotency stem (iPS) cells with embryonic stem cell characteristics (Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Yu et al., 2007) . iPS cell technology has fueled much excitement in regenerative medicine, as these cells could be differentiated to generate ''replacement'' cell therapeutics. Patient iPS cell-derived neurons have also been proposed to serve as neurodegenerative disease models (Abeliovich and Doege, 2009) .
A limitation to human iPS cell technology is that it remains inefficient (less than 1% of cells are typically reprogrammed) and time intensive; iPS cell generation and subsequent differentiation to a neuronal phenotype can take 1-2 months each. Furthermore, the pluripotent state is associated with tumorigenesis and genetic instability (Pera, 2011) . Recently, the directed conversion of rodent skin fibroblasts to a neuronal fate was reported, utilizing a set of three forebrain transcription regulators and apparently circumventing the production of a pluripotent intermediate state (Vierbuchen et al., 2010) . Here, we describe the directed conversion of adult human fibroblasts to a neuronal phenotype, termed human-induced neuronal (hiN) cells. To validate the approach, we show that hiN cells display electrophysiological properties of forebrain glutamatergic neurons and can integrate into mammalian CNS circuitry.
We further apply hiN cell technology to a panel of skin fibroblasts derived from patients with sporadic or familial forms of Alzheimer's disease (AD) and examine AD-associated neuronal pathologies. AD patients typically present with age-associated cognitive dysfunction, including reduced short-term (episodic) memory and spatial disorientation. These cognitive deficits are associated with neuronal and synaptic loss that is most prominent within the medial temporal lobe of the cerebral cortex and the hippocampus (Alzheimer, 1907) . Additional pathological features of AD include extracellular amyloid plaques composed largely of Ab fragments of amyloid precursor protein (APP) and intraneuronal tangles of Tau-paired helical filaments (Hardy and Selkoe, 2002) . Rare, autosomal, dominantly inherited familial forms of AD (FAD) are caused by mutations in APP or in the two presenilin genes (presenlin-1 and -2, or PSEN1 and PSEN2) that encode components of the g-secretase enzyme complex that is required for APP cleavage to Ab (Hardy and Selkoe, 2002) .
The amyloid hypothesis of AD, which is based on the aforementioned pathological and genetic findings, proposes that modified cleavage of APP by b-secretase and g-secretase leads to the generation of a pathogenic Ab42 fragment. Consistent with this hypothesis, expression of disease-associated PSEN FAD mutations in cell and animal models leads to preferential accumulation of Ab42 isoform relative to an Ab40 isoform. Nonetheless, basic questions regarding the pathogenic mechanism of PSEN FAD mutations remain (De Strooper and Annaert, 2010; Shen and Kelleher, 2007) . For instance, although PSEN FAD mutations increase relative Ab42 production, they paradoxically reduce total g-secretase activity, at least in cell-free and heterologous cell overexpression systems (Bentahir et al., 2006; Walker et al., 2005) . The potential role of reduced g-secretase activity in the disease process remains controversial. As the majority of studies to date rely on exogenous overexpression of PSEN FAD mutations in tumor cells, transgenic mice, or skin fibroblasts, the impact of endogenous PSEN FAD mutations on functional human patient neurons remains unclear. Moreover, why mutations in the broadly expressed PSEN-1 and -2 genes lead to a selective neuronal pathology is an open question.
RESULTS

Phenotypic Characterization of hiN Cells
We initially attempted to convert human adult skin fibroblasts (STC0022; see Table S1 available online) to hiN cells by viral cotransduction of a combination of three transcription regulators-Ascl1, Brn2, and Myt1l-that were shown to be effective for reprogramming of rodent cells (Vierbuchen et al., 2010) . These attempts were unsuccessful and led to prominent apoptotic cell death. Viral cotransduction of a larger set of forebrain transcription regulators-Brn2, Myt1l, Zic1, Olig2, and Ascl1, in the presence of neuronal survival factors (including brain-derived neurotrophic factor [BDNF], , and glialconditioned media [GCM] ), resulted in the generation of cells with a neuronal morphology (human-induced neuronal cells, or hiN cells) ( Figures 1A-1N ). Three weeks after viral transduction, hiN cells were positive for neuronal markers, including Tuj1, MAP2, Tau1, NeuN, NCAM, and Neurofilament-160 kd Figure S1 ). Such cells were never observed in fibroblast cultures transduced with control vector only ( Figures 1H and 1I ). Cell staining with the astroglial marker glial fibrillary acidic protein (GFAP) was not detected in hiN cell cultures ( Figure S1 ). More than 90% of MAP2-positive cells were positive for the neocortical glutamate neuron marker Tbr1 ( Figure 1K ), and theseTbr1-positive cells did not express the fibroblast marker, fibroblast-specific protein-1 (FSP1; Figure 1L ). Approximately half of the MAP2-positive cells were positive for the mature glutamatergic neuron marker vesicular glutamate transporter-1 (vGLUT1) in a stereotypical punctate pattern (Figure 1M) . Only rare MAP2-positive cells (less than 1%) displayed the GABAergic neuron marker, glutamic acid decarboxylase-65 (GAD65; Figure 1N ).
We applied our hiN cell conversion protocol to a panel of nine adult human skin fibroblast lines in total (see Table S1 ). Quantitative analysis indicates that conversion efficiency of fibroblasts to MAP2-positive hiN cells across these lines ranged from 7.1% to 8.9% (as a percentage of input fibroblasts; n = 3 per group). After accounting for cell attrition during the 3 week culture, 28.4%-36.1% of the surviving cells were MAP2 positive (Figure 1O ). Across these lines, 48.2%-60.9% of the MAP2-positive cells were also positive for vGLUT1 ( Figure 1P ).
Time course analysis indicated that MAP2-and vGLUT1-positive hiN cells first appear by day 7 after viral vector transduction and that maximal conversion occurs by 21 days (Figure 2A ). After 21 days, hiN cell number decreased, and this was accompanied by evidence of apoptosis ( Figure 2A and Figures S2C-S2G ). Remaining cells displayed progressively elongated processes, as expected ( Figure S2B ). To determine the minimal factors that are necessary and sufficient to generate hiN cells, we removed individual transcription factor vectors or extrinsic components from the conversion protocol. These data indicated that Ascl1 and Brn2 are essential for the process, whereas Zic1 and Myt1l modify efficiency, and Oligo2 appears to be redundant (Figure 2B ). After transduction with viral factor cocktails, converted cells maintained expression of the extrinsic virally encoded Ascl1, Brn2, and Myt1l transcription factors, as determined by RT-PCR analysis, whereas extrinsic Zic1 expression was maintained only in a subset of cultures ( Figure S2A ). Maintenance of exogenous factor expression may have contributed to the apoptotic loss of hiN cells with extended culturing. Of the tested soluble extrinsic factors, only BDNF appeared essential for production of MAP2 + /vGLUT1 + cells ( Figure 2B and Figure S2D ).
A single polycistronic lentivirus vector harboring the genes Ascl1, Brn2, and Zic1 (ABZ vector) was sufficient for the conversion process ( Figure 2C and Figures S2K-S2N ). ABZ vectormediated conversion was highly efficient and could be further enhanced by adding Myt1l ( Figure 2C and Figures S2O-S2V ). Specifically, 62% ± 6% of the adult human fibroblasts that were transduced with the ABZ vector and 85% ± 15% of the cells that were transduced with the ABZ vector and Myt1 acquired a MAP2-positive neuronal morphology phenotype ( Figure 2C and Figures S2L-S2Q ). These hiN cells expressed additional neuron markers, including Tau-1, Tuj1, Tbr1, and vGLUT1 ( Figures S2R-S2V ).
To further characterize the hiN cell phenotype, we performed whole-transcriptome gene expression profiling on neurons that were purified from hiN cell cultures. hiN cell cultures were subjected to fluorescence-activated cell sorting (FACS; Figures S2H-S2J) to select for neural cell adhesion molecule (NCAM, a marker for mature neurons as well as some neural progenitors)-positive cells. RNA preparations from FACS-purified hiN cells, total (''mixed'') cultures, and unconverted fibroblasts were then analyzed for genome-wide expression (Table S2) . Hierarchical clustering analysis demonstrated that the transcriptome profiles of purified hiN cells were more similar to each other than to the originating fibroblasts ( Figure 2D ). Using gene ontology (GO) functional annotation, we identified genes that are most enriched within the purified hiN cell samples relative to the fibroblast samples (upregulated by at least 4-fold with a significance analyses of microarrays false discovery rate [FDR] cutoff of less than 25%). Consistent with a neuronal phenotype, the most highly enriched, functionally annotated gene sets in the purified hiN samples included ''axonal projection Table  S2 ). Finally, we performed hierarchical clustering to broadly compare hiN cell gene expression profiles to those seen in human neurons (isolated from postmortem brain samples) and R E T R A C T E D other cell types. As expected, FACS-sorted hiN cell samples clustered most closely with CNS neurons rather than fibroblasts, astrocytes, neural progenitors, or pluripotent ES or iPS cells ( Figure S3 ). Table S1 ) were transduced with the five transcription regulators, cultured for 3 weeks as in (A), and subsequently immunostained with antibodies specific to Tuj1 (B and E; in red), MAP2 (C; in green), or Tau Figure S1 and Table S1 .
hiN Cell Reprogramming Is Directed Consistent with the idea that the hiN cell phenotype can be achieved without neuronal progenitor intermediates, expression of the progenitor markers Sox2 and Pax6 was not apparent during hiN cell reprogramming ( Figures 3A-3C and 3E-3G). Expression of Nestin, which is associated with neuronal progenitors but also functions more generally as a cytoskeleton regulator during morphological cell changes (Gilyarov, 2008) , appeared transiently in a subpopulation of cells (<10%;
Figures 3I and 3M-3O). In contrast to hiN cell reprogramming, differentiation of human iPS cells to a neural progenitor state led to the robust accumulation of Sox2-positive, Pax6-positive, and Nestin-positive progenitors, as expected ( Figures 3D, 3H , and 3L). RNA expression profiling by real-time quantitative RT-PCR similarly indicated that expression of neuronal progenitor markers such as FOXG1 and OTX2 was absent from hiN cell cultures ( Figure 3P ). Figure 4E ; confirmed in 3 of 4 cells analyzed). Consistent with such channel properties, most hiN cells were able to fire at least one action potential in response to depolarizing current injections in current clamp mode ( Figure 4F ; 9 of 10 cells analyzed). Furthermore, upon termination of hyperpolarizing pulses, cells displayed a typical rebound spike ( Figure 4F ). Passive membrane properties were also consistent with an in vitro neuronal phenotype, with a resting membrane potentials ranging from À67 mV to À32 mV (average À52 mV; n = 17), membrane time constant (t) ranging from 1.00 to 0.30 ms, membrane resistance (R m ) ranging from 0.12 to Table S1 ). hiN cell preparations clustered together, rather than with the originating fibroblast preparations. (E and F) The five most significantly enriched gene ontology (GO) categories among the genes upregulated (E) or downregulated (F) in the context of hiN cell conversion are presented. Expression data were analyzed using a false discovery rate of less than 25% and a log-ratio threshold of > 2. Nominal p values are listed.
Physiological Properties of hiN Cells
(G) Heat map specifying the genes and expression values within the GO category ''neuron projection'' as in (E). Relative expression levels of individual genes (as labeled on rows) are presented from low (green) to high (red) as per the color chart bar at the bottom. Cell samples are labeled as per (D). See also Figure S2 , Figure S3 , and Table S2 . larization-evoked fluorescence intensity changes were apparent within the axon-like processes of hiN cells (Figure 4K ; seen in 6 of 10 cells), which are thought to represent putative synaptic release sites (Forti et al., 2000) .
hiN Cells Can Integrate into Neuronal Circuitry In Vitro and In Vivo
We did not observe spontaneous activity that is suggestive of neuronal connectivity in hiN cells voltage clamped at À70 mV using the standard culture conditions as above (n = 16 of 16 cells tested). We therefore sought to develop alternative protocols that may provide the appropriate environmental cues for synaptic maturation. First, as glial cells can play a major role in the regulation of neuronal synaptic development and connectivity (Eroglu and Barres, 2010) , hiN cells were cocultured with murine glial cells (obtained from mice ubiquitously expressing red fluorescent protein) (Muzumdar et al., 2007) . After 2 weeks of coculture, whole-cell patchclamp recordings of hiN cells (identified as nonfluorescent cells with a neuronal morphology) held at À70 mV revealed spontaneous membrane current changes that were sensitive to glutamatergic receptor inhibition with NBQX and APV (Figures 5A-5C; n = 6 of 10 cells tested). Second, GFP-labeled hiN cells were transplanted in utero into embryonic day 13.5 mouse brain (Brü stle et al., 1997) . The transplanted cells migrated from the ventricles into various brain regions, as expected ( Figures 5D and 5E and Table S3 ). The identity of GFP-positive transplanted hiN cells was confirmed by immunostaining with an antibody specific for human NCAM ( Figure 5F ). Voltage-clamp recordings from GFP-positive hiN cells within acutely prepared brain slices from postnatal day 7 pups demonstrated spontaneous currents of various amplitudes and frequencies ( Figure 5G ; n = 3). These events increased in frequency and amplitude upon blockade of GABA A receptors with picrotoxin ( Figure 5H ) and were suppressed with the glutamatergic receptor channel inhibitors NBQX and APV ( Figure 5I ). We confirmed the identity of the recorded cell by dual fluorescence imaging (Figures S4A and S4B) . Subsequent to the recording, slices were immunostained to demonstrate expression of the human-specific mitochondrial marker hMito within recorded cells ( Figure S4C ; n = 3). Together, Generation of hiN Cells from FAD and SAD Patient Skin Fibroblasts As proof of principle for their utility in disease modeling, we generated hiN cells from a panel of human skin fibroblasts derived from patients with familial AD (FAD) due to mutations in PSEN-1 or -2, patients with sporadic AD (SAD), or unaffected individuals (UND; n = 3 per each group). Given the likely heterogeneity of ''sporadic'' disease and the limited number of samples examined in our study, we subsequently focused herein on phenotypic examination of the familial lines. hiN cells derived from disease- See also Figure S4 and Table S3. associated fibroblasts appeared similar to those from unaffected individuals with respect to neuronal reprogramming characteristics, such as efficiency of MAP2-positive hiN cell generation and the percentage of neurons that express vGLUT1 ( Figures 1O and 1P) . Induction of expression of the mature neuron marker synaptophysin was comparable among the hiN cell cultures, as determined by quantitative real time RT-PCR analysis ( Figure S5A ), and cell density at 3 weeks was not significantly different across the hiN cell cultures ( Figure S5B ).
APP Processing in FAD-and SAD-Derived hiN Cells
We next evaluated AD-associated phenotypes in the hiN cell cultures, including the processing of amyloid precursor protein (APP) to the Ab42 and Ab40 fragments. FAD patient brain is typified by an increased Ab42/Ab40 ratio (Hardy and Selkoe, 2002) . Consistent with this, the Ab42/Ab40 ratio was dramatically increased in FAD hiN cell cultures relative to UND hiN cell R E T R A C T E D cultures, as quantified in cell media by ELISA ( Figure 6A ; p < 0.001, ANOVA with post hoc Tukey HSD; n = 3 patient lines per FAD or UND group with 11-16 independent cultures per line). Similarly, on a pooled analysis of all FAD hiN versus all UND hiN cultures, the Ab42/Ab40 ratio is significantly increased in the FAD group (p < 1 3 10 À9 ; ANOVA with post hoc Tukey HSD; n > 38 per group). The increased Ab42/Ab40 ratio is most evident in the AG07768 line, but even in the absence of those AG07768 samples, the FAD group displayed an elevated Ab42/Ab40 ratio (p < 1 3 10 À9 ; ANOVA with post hoc Tukey HSD, n > 29 per group). Importantly, the Ab42/Ab40 ratio in FAD hiN cell cultures was also elevated relative to the originating FAD fibroblast cultures (p < 1 3 10 À9 ; ANOVA with post hoc Tukey HSD; n > 38 per group). In contrast, the Ab42/Ab40 ratio in UND hiN cell cultures was not significantly elevated relative to the originating UND fibroblast cultures (p > 0.05; ANOVA with post hoc Tukey HSD; n > 30 per group). FAD hiN cell conversion led to an increase in the level of total Ab (combined Ab42 and Ab40 polypeptides) relative to the originating FAD fibroblasts ( Figure 6B ; p < 0.05; ANOVA with post hoc Tukey HSD; n = 3 individual lines per group, with 11 to 16 independent wells for each line). Such an increase in total Ab with hiN cell conversion was not apparent in the context of UND cultures. Taken together, these data indicate that hiN cell conversion appears to amplify an FAD-associated phenotype in the context of PSEN1 or PSEN2 mutations. Levels of APP holoprotein (the Ab42 and Ab40 precursor) did not differ significantly between hiN cell cultures from FAD patients versus UND controls, as quantified by ELISA on cellular lysates ( Figure 6C ) or by quantitative real-time RT-PCR on RNA transcripts ( Figure S5C ). However, in comparison to the original fibroblast cultures, holoprotein expression was consistently elevated with all hiN cell cultures regardless of origin ( Figure 6C ). Because hiN cultures from FAD and UND genotypes displayed similar levels of APP, it is unlikely that APP levels account for the selective generation of Ab42 in FAD hiN cells. Using coimmunostaining with antibodies to Ab42, Ab40, and MAP2, we further observed that both isoforms of Ab are selectively increased in the MAP2-positive neuronal cells, but not in the remaining fibroblastic cells, that compose the mixed hiN culture ( Figures 6D  and Figures S5H-S5J) . 
R E T R A C T E D
Cleavage of APP by BACE1 b-secretase activity is thought to be a rate-limiting step in the production of Ab and precedes cleavage by g-secretase (Thinakaran and Koo, 2008) . We thus quantified the soluble extracellular cleavage product of APP by BACE1, termed sAPPb, in the hiN cell cultures. There was a consistent increase in the sAPPb product in converted FAD and UND hiN cell cultures relative to their respective fibroblasts. However, accumulation of sAPPb was not significantly elevated in hiN cell cultures from FAD patients relative to hiN cell cultures from UND individuals ( Figure 6E ). BACE1 transcript levels, as determined by quantitative real-time RT-PCR, did not appear altered in hiN cell cultures relative to fibroblasts, regardless of disease status ( Figure S5D ). Thus, the elevated level of Ab42 in hiN-FAD is not caused by increased activity of BACE1.
Altered APP-Positive Endocytic Compartment Morphology in FAD hiN Cells
Immunocytochemical analysis of hiN cells with an antibody to the APP amino terminus domain revealed the presence of APP-positive puncta within soma ( Figures 7A and 7B ). In contrast, such APP-positive punctate structures were not readily apparent in the originating fibroblasts. Quantitative analysis of APP staining of hiN cells revealed that APP-positive puncta (defined as 0.1 to 1 mm in diameter) are significantly increased in FAD-derived hiN cell cultures, relative to UND hiN cells, quantified in terms of total puncta area per cell ( Figure 7C ; FAD, 78.2 ± 10.93 mm 2 ; UND, 23.8 ± 3.28 mm 2 ). This is due to an increased number of puncta per cell as well as an increased average size of puncta ( Figures S6A and S6B ). Similar findings were apparent with a second independent antibody to APP ( Figure S6I ). Pathological studies of sporadic AD patients at autopsy have reported evidence for alteration in the size of intracellular vesicular endocytic (Cataldo et al., 1997) and lysosomal (Cataldo et al., 1996) compartments.
APP processing by the b-and g-secretase activities may largely proceed within vesicular endosomal compartments (Tang, 2009) . We thus further characterized the APP-positive punctate structures in hiN cells by costaining with antibodies for a panel of vesicular compartment and plasma membrane markers. Subpopulations of APP-positive puncta in hiN cells stained positively for an early endosomal marker, early endosome-associated antigen-1 (EEA1); a late endosomal marker, the cation-independent mannose 6-phosphate receptor (MPR); and a lysosomal marker, the lysosomal associated marker protein-2 (LAMP2). Localization to the plasma membrane at the cell periphery was also observed (quantified in terms of colocalization at a membrane dye, CellMask). Of these populations, the EEA1-positive, APP-positive compartment was significantly increased in FAD hiN cells relative to UND cells, as quantified by the percentage of APP-positive puncta stained with EEA1 (Figures 7D-7F ; FAD, 24% ± 2%; UND, 13% ± 1%). In contrast, APP puncta staining at the plasma membrane appeared significantly reduced in the FAD hiN cells (FAD-hiN, 2.1% ± 1.3%; UND-hiN, 6.3% ± 1.0%; Figures 7G-7I ). APPpositive endocytic puncta also stained for BACE1 ( Figure 7J -7L and Figure S6I ; FAD, 54.2 ± 2.91 mm 2 ; UND, 16.5 ± 0.83 mm 2 ), as expected given the known localization of BACE1 (Vassar et al., 1999) . Finally, we note that EEA1-positive and MPR-positive puncta were generally enlarged in FAD cells ( Figures 7D-7F and Figures S6C-S6E) , regardless of costaining with APP, indicative of a broadly altered endocytic compartment, rather than a specific defect in APP-positive structures. We next sought to clarify whether altered APP-positive puncta morphology in FAD-derived hiN cells might simply be a secondary consequence of Ab accumulation. Treatment with a g-secretase inhibitor, DAPT, which suppressed production of Ab ( Figures S6K and S6L) , did not prevent increased APP-positive puncta area per cell in the context of the FAD lines ( Figures  7M-7O) . Rather, we found that DAPT treatment of UND hiN cells, but not FAD hiN cells, partially phenocopied the magnified APPpositive intracellular compartment (Figures 7M-7O) . Thus, the increased APP-positive puncta seen with DAPT of UND hiN cells was occluded in the context of FAD hiN cell cultures (that already harbor increased total APP-positive puncta).
Finally, to relate the altered intracellular APP-positive puncta in FAD hiN cells to FAD mutations, we performed a ''rescue'' experiment by overexpressing wild-type PSEN1 into FAD PSEN1 mutant hiN cells. Although FAD mutations are dominantly inherited in human patients, it is well described that overexpression of PSENs leads to preferential replacement of the endogenously encoded form by the exogenous overexpressed gene product (in part, a consequence of reduced stability of the endogenously encoded gene product; Thinakaran et al., 1997) . Consistent with this, we found that overexpression of wild-type PSEN1 by transfection of a plasmid vector into hiN cell cultures rescued the endosomal APP-positive endocytic phenotype; transfection of this vector into UND cells did not appear to alter intracellular APP-positive puncta staining (Figures 7P-7R ). These findings suggest that the FAD phenotype is caused, at least in part, by abnormal endocytic function, which is dependent on PSEN.
DISCUSSION
A major goal in regenerative medicine is the facile generation of human neurons for cell replacement therapeutics or disease modeling. The description of hiPS cell reprogramming methods for the generation of pluripotent cells has fueled excitement in the field. But as hiPS cell generation is complex, time consuming, and associated with tumorigenicity and genomic DNA rearrangements (Pera, 2011) , alternative approaches are of interest. By comparison to hiPS cell reprogramming, hiN cell conversion offers a more directed route to terminally differentiated neurons.
Our analysis of FAD patient-derived hiN cell cultures underscores the potential utility of such human neuronal disease models. hiN cells from PSEN mutant FAD patient fibroblasts display an increased Ab42/Ab40 ratio relative to UND hiN cells, consistent with patient brain pathology and with the well-characterized role of PSENs as essential components of the g-secretase complex (Hardy and Selkoe, 2002) . Surprisingly, the impact of FAD PSEN mutations on the Ab42/Ab40 ratio was amplified upon hiN cell conversion from fibroblasts. This suggests a model in which PSEN FAD mutants may alter APP processing at multiple levels: directly through modified g-secretase activity, as well as indirectly with altered cellular context. Consistent Prior pathological autopsy studies of early-stage AD patient brain have reported the presence of altered endosomal, lysosomal, and autophagy compartments (Nixon and Cataldo, 2006) . Furthermore, a complete deficiency of PSEN-1 and -2 in fibroblasts can impair endosomal trafficking (Repetto et al., 2007) . However, the impact of FAD PSEN mutations on neuronal APP-positive endosomal structures has not previously been characterized. Our analysis further indicates that g-secretase inhibition in UND hiN cell cultures appears to mimic the APPpositive endosomal compartment phenotype of FAD cultures, suggesting a role for reduced g-secretase activity in this FAD phenotype. It remains possible that FAD-associated endosomal compartment modifications, as observed in FAD hiN cells, play a pathogenic role in AD independent of Ab. The issue is complicated by the many functionally heterogeneous FAD-associated PSEN1 and PSEN2 mutations. An important limitation to our present study is that we evaluate only two such forms, and thus future studies with additional lines would likely be informative.
Examination of FAD hiN cell models for additional AD-associated pathological findings, such as defective synaptic function, will be of interest. To this end, the ability of hiN cells to functionally integrate into neuronal circuitry will be particularly useful. It is also conceivable that such integration of hiN cells into murine AD disease models will test the therapeutic potential of hiN cells. Finally, we note that, in the future, it may well be feasible to evaluate mechanisms of sporadic AD pathology using hiN cell models.
EXPERIMENTAL PROCEDURES Human Skin Fibroblasts
Human skin fibroblast cultures from nine individuals were used in this study (see Table S1 ). All lines were derived from de-identified, banked tissue samples. Human skin fibroblasts were cultured in standard fibroblast media (see Extended Experimental Procedures).
Plasmid Construction and Lentiviral Production cDNAs for the reprogramming factors were cloned into lentiviral vectors either individually or as a polycistronic set (for Ascl1, Brn2, and Zic1; see Extended Experimental Procedures for cloning details). Production of replication-incompetent lentiviral particles was as described (MacLeod et al., 2006) . Human wild-type PSEN1 cDNA (Openbiosystems) was cloned into the pLenti6.3/ V5-Dest vector using the Gateway LR cloning system (Invitrogen).
hiN Cell Induction and Transfection Fibroblasts were transduced with replication-incompetent, VSVg-coated lentiviral particles encoding Ascl1, Brn2, Myt1l, Oligo2 , and Zic1 at a multiplicity of infection of 2:1 and were maintained in fibroblast media for 2 days (see Extended Experimental Procedures). Subsequently, the media was replaced with glial-conditioned N2 media (GCM; DMEM/F12 with N2 supplement; Invitrogen) containing 20 ng/ml BDNF and 20 ng/ml NT3 (Peprotech). For the first 4 days in GCM, dorsomorphin (1 mM; Stemgent) was also supplemented. Media was changed every 2-3 days for the duration of the culture period. For the PSEN1 rescue study, cells were transfected with pLenti6.3/V5-Presenilin1 and pEGFP-C1 plasmids (9:1) using the Lipofectamine 2000 reagent (DNA: LF2000 1 mg: 5 ml in each well of 24 well, Invitrogen).
Immunocytochemistry, Immunohistochemistry, and RT-PCR Immunocytochemistry and immunohistochemistry (IHC) were performed as previously described (MacLeod et al., 2006) . Detailed antibody sources and dilutions utilized can be found in the Extended Experimental Procedures. Imaging was conducted by laser scanning confocal microscopy with a 633/1.4 objective (LSM510, Carl Zeiss) or epifluorescence microscope (Olympus 1X71; Japan). Cell counts and fluorescence intensities were quantified within 10-35 images of randomly selected views per well. Subsequently, images were analyzed for cell counts and fluorescent intensity using Image J 1.42q software (National Institute of Health, USA). Values are presented as mean ± SEM. Quantitative real time RT-PCR was performed as described (Rhinn et al., 2008) ; primer pairs utilized are detailed in the Extended Experimental Procedures. Gene expression levels were quantified by the DDCt method (Rhinn et al., 2008) . and then sorted on a FACS Aria IIu (BD Bioscience, CA) directly into RNA lysis solution (Ambion, TX). RNA was extracted from cell preparations using the RNAqueous Micro Kit (Ambion). Concentration and quality of RNA were assessed using the Bioanalyzer system (Agilent). mRNA was amplified and labeled using Ovation Pico WTA System (Nugen) and was subsequently hybridized to Human Genome U133 Plus 2.0 Arrays (Affymetrix). Raw data were processed using the R statistical computing environment Affymetrix Linear Modeling Graphical User Interface package (affylmGUI). Computational methods are detailed in the Extended Experimental Procedures.
In Utero Transplantation
Human skin fibroblasts (STC0022) were labeled by transduction with a GFPencoding lentiviral vector and then passaged three times over 10 days prior to initiation of hiN cell induction to remove residual lentivirus. hiN induction was then performed using the lentiviral vectors encoding Ascl1, Brn2, Myt1l, Oligo2, and Zic1, as described above. At 7-10 days later, cells were trypsinized and triturated to single-cell suspensions in the presence of 0.1% DNase (QIAGEN). Timed pregnant C57BL/6N mice at day 13.5 of gestation were anesthetized with oxygen containing 2% isoflurane administered through an inhalation mask, and 2-5 3 10 5 cells were injected into the telencephalic vesicle of each embryo as described (Brü stle et al., 1997) . Transplanted mice were spontaneously delivered and analyzed at the time points indicated. Following deep isoflurane anesthesia, mice were euthanized, and the brains were rapidly removed and fixed in 4% paraformaldehyde for 2 days. For IHC, 50 mm sections were cut with a vibrating blade microtome.
Electrophysiology and Calcium Imaging
Tight-seal whole-cell recordings (WCR) were performed with borosilicate glass pipettes (resistance 5-8 MU) using an Axopatch 200B amplifier (Axon Instruments). Recordings from transplanted cells were performed in acutely prepared brain slices (180 mm thick) through the entire cerebrum, as described in detail (Llano and Bezanilla, 1980) . For glial coculture studies, murine astroglial cells were prepared as previously described (Kaech and Banker, 2006) increase in total APP-positive puncta area per cell within UND, but not FAD, cultures. Results represent mean ± SEM (n = 35-50 cells in 3 independent wells). *p < 0.05. (P-R) Rescue of the endosomal APP-positive endocytic phenotype in PSEN1 mutant FAD hiN cells. UND (P, STC0022) and PSEN1 mutant FAD (Q, AG07768) hiN cell cultures were transfected with an expression vector for human wild-type PSEN1 or empty vector (along with EGFP to mark transfected cells). Cultures were incubated for an additional 72 hr and subsequently immunostained for APP. Results represent the mean ± SEM (n = 35-50 cells in 3 independent wells per group). *p < 0.05. See also Figure S6 .
R E T R A C T E D
from mice ubiquitously expressing red fluorescent protein (Muzumdar et al., 2007) . For calcium imaging, Oregon Green-BAPTA 1 (OG1; Molecular Probes) was added at a concentration of 100 mM. Fluorescent imaging was conducted using a digital EM-CCD camera (Andor ixon) with an LED light source (Cairn).
Values are expressed as the percentage of change in fluorescence signal with respect to prestimulus control, DF/F 0 = 100 3 (F À F 0 )/(F 0 À B), wherein F is the fluorescence at any given time, F 0 the average at the prestimulus period, and B the average value of the background fluorescence at each time point, as quantified in four regions of the imaged field that do not contain any part of the dyefilled cell.
Sandwich ELISAs APP ELISA was performed using a human APP ELISA kit (Invitrogen, Camarillo, CA), according to the manufacturer's instruction. Absorbance was read on a VersaMax ELISA Microplate Reader (Molecular Devices, Inc., Sunnyvale, CA) at 450 nm. The amount of APP was normalized to the total cell protein (determined with the DC Protein Assay Reagent kit; Bio-Rad, Hercules, CA). sAPPb ELISA was performed using BetaMark sAPP Beta ELISA kit (Covance, Princeton, NJ), according to the manufacturer's instruction. The chemiluminescence was read on a microplate luminometer (SPECTRAFluoR Plus, TECAN, Mä nnedorf, Switzerland). Ab quantification was performed by ELISA as described previously (Cirrito et al., 2003) . 
Statistical Analysis
